ArticleNature reviews. Molecular cell biology2021
Author Correction: Guidelines and definitions for research on epithelial-mesenchymal transition.
Abstract readPublished Erratum
In one paragraph
Article in Nature reviews. Molecular cell biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed.
- Hallmarks of epithelial-mesenchymal plasticity in cancer.Molecular cancer · 2026Review
- MFAP2 promotes metastasis and drug resistance by regulating epithelial-to-mesenchymal transition through EGFR signaling pathway in colorectal cancer cells.Genes & diseases · 2026Article
- Rewiring miR-22/SNAI1 via CRISPR-based edge editing destabilizes the epithelial phenotype.NPJ systems biology and applications · 2026Article
- The Pro-Metastatic Roles of ROS.Antioxidants (Basel, Switzerland) · 2026Review
- Force coordination distinguishes epithelial and mesenchymal modes of collective chemotaxis.The Journal of cell biology · 2026Article
- The oncogenic role of mir-21 in cervical cancer: linking epithelial-mesenchymal transition to stromal remodeling.Frontiers in oncology · 2026Review
- Identification and functional characterization of genes associated with lipopolysaccharide in lung adenocarcinoma.BMC cancer · 2025Article
- Scar wars: the viral menace.American journal of physiology. Lung cellular and molecular physiology · 2025Review
- Circulating tumor cells: mechanisms and clinical significance in colorectal cancer metastasis.Molecular cancer · 2025Review
- Natural and induced epithelial-mesenchymal transition results in epigenetic silencing of HER2 overexpression.Journal of mammary gland biology and neoplasia · 2025Article
- Epigenetic regulation of cancer stemness.Signal transduction and targeted therapy · 2025Review
- Accumulation of CD38 in Hybrid Epithelial/Mesenchymal Cells Promotes Immune Remodeling and Metastasis in Breast Cancer.Cancer research · 2025Article
- Prolonged DEHP exposure enhances the stemness and metastatic potential of TNBC cells in an MSI2-dependent manner.International journal of biological sciences · 2025Article
- Role of PRMT1 and PRMT5 in Breast Cancer.International journal of molecular sciences · 2024Review
- Novel 1,4-Dihydropyridines as Specific Binders and Activators of SIRT3 Impair Cell Viability and Clonogenicity and Downregulate Hypoxia-Induced Targets in Cancer Cells.Journal of medicinal chemistry · 2023Article
- Pleckstrin-2-promoted PPM1B degradation plays an important role in transforming growth factor-β-induced breast cancer cell invasion and metastasis.Cancer science · 2023Article
- ENO2 affects the EMT process of renal cell carcinoma and participates in the regulation of the immune microenvironment.Oncology reports · 2023Article
- SDR16C5 promotes proliferation and migration and inhibits apoptosis in pancreatic cancer.Open life sciences · 2023Article
- Emerging role of ferroptosis-related circular RNA in tumor metastasis.Frontiers in pharmacology · 2023Review
- Long Noncoding RNA and Circular RNA: Two Rising Stars in Regulating Epithelial-Mesenchymal Transition of Pancreatic Cancer.Frontiers in oncology · 2022Review
Corrections and comments
- Erratum for
Authors and funding
48 authors.
Jing YangDepartments of Pharmacology and Pediatrics, Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA. jingyang@ucsd.edu.ORCID http://orcid.org/0000-0001-8410-3549
Parker AntinDepartment of Cellular and Molecular Medicine, University of Arizona, Tucson, AZ, USA.
Geert BerxMolecular and Cellular Oncology Lab, Department of Biomedical Molecular Biology, Ghent University, Cancer Research Institute Ghent (CRIG), VIB Center for Inflammation Research, Ghent, Belgium.
Cédric BlanpainLaboratory of Stem Cells and Cancer, Université Libre de Bruxelles, Bruxelles, Belgium.
Thomas BrabletzDepartment of Experimental Medicine 1, Nikolaus-Fiebiger-Center for Molecular Medicine, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany.
Marianne BronnerDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA.
Kyra CampbellDepartment of Biomedical Science and Bateson Centre, University of Sheffield, Sheffield, UK.
Amparo CanoDepartamento de Bioquímica, Universidad Autónoma de Madrid (UAM), Instituto de Investigaciones Biomédicas 'Alberto Sols' (CSIC-UAM), IdiPAZ & Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
Jordi CasanovaInstitute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology/Institut de Biologia Molecular de Barcelona (IBMB-CSIC), Barcelona, Spain.
Gerhard ChristoforiDepartment of Biomedicine, University of Basel, Basel, Switzerland.
Shoukat DedharDepartment of Biochemistry and Molecular Biology, University of British Columbia and British Columbia Cancer Research Centre, Vancouver, BC, Canada.
Rik DerynckDepartments of Cell and Tissue Biology, and Anatomy, University of California at San Francisco, San Francisco, CA, USA.
Heide L FordDepartment of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Jonas FuxeDepartment of Laboratory Medicine (LABMED), Division of Pathology, Karolinska University Hospital and Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, Stockholm, Sweden.ORCID http://orcid.org/0000-0003-4576-9377
Antonio García de HerrerosPrograma de Recerca en Càncer, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM) and Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra, Barcelona, Spain.
Gregory J GoodallCentre for Cancer Biology, An alliance of SA Pathology and University of South Australia, Adelaide, SA, Australia.
Anna-Katerina HadjantonakisDevelopmental Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Ruby Y J HuangSchool of Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.
Chaya KalcheimDepartment of Medical Neurobiology, Institute for medical Research Israel-Canada and the Safra Center for Neurosciences, Hebrew University of Jerusalem, Hadassah Medical School, Jerusalem, Israel.
Raghu KalluriDepartment of Cancer Biology, Metastasis Research Center, MD Anderson Cancer Center, Houston, TX, USA.
Yibin KangDepartment of Molecular Biology, Princeton University, Princeton, NJ, USA.ORCID http://orcid.org/0000-0002-1626-6730
Yeesim Khew-GoodallCentre for Cancer Biology, an Alliance of SA Pathology and the University of South Australia, Adelaide, SA, Australia.
Herbert LevineDepartment of Physics, Northeastern University, Boston, MA, USA.
Jinsong LiuDepartment of Anatomic Pathology, The Division of Pathology and Laboratory Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Gregory D LongmoreDepartment of Medicine (Oncology) and Department of Cell Biology and Physiology, ICCE Institute, Washington University, St. Louis, MO, USA.
Sendurai A ManiDepartment of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Joan MassaguéCancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Roberto MayorDepartment of Cell and Developmental Biology, University College London, London, UK.ORCID http://orcid.org/0000-0001-9053-9613
David McClayDepartment of Biology, Duke University, Durham, NC, USA.
Keith E MostovDepartments of Anatomy and Biochemistry/Biophysics, University of California, San Francisco, School of Medicine, San Francisco, CA, USA.ORCID http://orcid.org/0000-0002-8123-6247
Donald F NewgreenMurdoch Children's Research Institute, Royal Children's Hospital, Parkville, VIC, Australia.ORCID http://orcid.org/0000-0002-3467-6389
M Angela NietoInstituto de Neurociencias (CSIC-UMH) Avda Ramon y Cajal s/n, Sant Joan d´Alacant, Spain.ORCID http://orcid.org/0000-0002-3538-840X
Alain PuisieuxUniversité Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Lyon, France.ORCID http://orcid.org/0000-0002-9938-3798
Raymond RunyanDepartment of Cellular and Molecular Medicine, University of Arizona, Tucson, AZ, USA.ORCID http://orcid.org/0000-0002-7410-916X
Pierre SavagnerINSERM UMR 1186, Integrative Tumor Immunology and Genetic Oncology, Gustave Roussy, University Paris-Saclay, Villejuif, France.
Ben StangerDepartment of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Marc P StemmlerDepartment of Experimental Medicine 1, Nikolaus-Fiebiger-Center for Molecular Medicine, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany.ORCID http://orcid.org/0000-0002-7866-3686
Yoshiko TakahashiDepartment of Zoology, Graduate School of Science, Kyoto University, Kyoto, Japan.
Masatoshi TakeichiRIKEN Center for Biosystems Dynamics Research, Kobe, Japan.ORCID http://orcid.org/0000-0002-9931-3378
Eric TheveneauCentre de Biologie du Développement (CBD), Centre de Biologie Intégrative (CBI), Université de Toulouse, CNRS, UPS, Toulouse, France.ORCID http://orcid.org/0000-0001-6510-5717
Jean Paul ThieryGuangzhou Regenerative Medicine and Health, Guangdong Laboratory, Guangzhou, China.ORCID http://orcid.org/0000-0003-0478-5020
Erik W ThompsonSchool of Biomedical Sciences and Institute of Health and Biomedical Innovation, Queensland University of Technology, Translational Research Institute, Woolloongabba, QLD, Australia.ORCID http://orcid.org/0000-0002-9723-4924
Robert A WeinbergWhitehead Institute for Biomedical Research, Department of Biology, MIT Ludwig Center for Molecular Oncology, Massachusetts Institute of Technology, Cambridge, MA, USA.
Elizabeth D WilliamsAustralian Prostate Cancer Research Centre-Queensland (APCRC-Q) and Queensland Bladder Cancer Initiative (QBCI), School of Biomedical Sciences and Institute of Health and Biomedical Innovation, Queensland University of Technology, Woolloongabba, QLD, Australia.ORCID http://orcid.org/0000-0002-3364-6655
Jianhua XingDepartment of Computational and Systems Biology and UPMC-Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.ORCID http://orcid.org/0000-0002-3700-8765
Binhua P ZhouDepartment of Molecular and Cellular Biochemistry and UK Markey Cancer Center, University of Kentucky College of Medicine, Lexington, KY, USA.
Guojun ShengInternational Research Center for Medical Sciences (IRCMS), Kumamoto University, Kumamoto, Japan. sheng@kumamoto-u.ac.jp.
EMT International Association (TEMTIA)
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.